AR048869A1 - Bencimidazoles triciclicos - Google Patents

Bencimidazoles triciclicos

Info

Publication number
AR048869A1
AR048869A1 ARP050101534A ARP050101534A AR048869A1 AR 048869 A1 AR048869 A1 AR 048869A1 AR P050101534 A ARP050101534 A AR P050101534A AR P050101534 A ARP050101534 A AR P050101534A AR 048869 A1 AR048869 A1 AR 048869A1
Authority
AR
Argentina
Prior art keywords
4alkyl
fluoro
4alkoxy
alkyl
cycloalkyl
Prior art date
Application number
ARP050101534A
Other languages
English (en)
Inventor
Buhr Wilm Dr
Zimmermann Peter Jan Dr
Brehm Christof Dr
Andreas Palmer
Chiesa M Vittoria Dr
Simon Wolfgang-Alexander Dr
Postius Stefan Dr
Dr Kromer Wolfgang Prof
Joerg Senn-Bilfinger
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of AR048869A1 publication Critical patent/AR048869A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente trata de bencimidazoles tricíclicos, los compuestos inhiben la secrecion de ácido gástrico. Medicamento y uso. Reivindicacion 1: Un compuesto de la formula (1) en donde R1 es H, halogeno, C1-4 alquilo, C3-7 cicloalquilo, C3-7cicloalquil- C1-4alquilo, C1-4 alcoxi, C1-4alcoxi-C1-4alquilo, C1-4 alcoxicarbonilo, C2-4 alquenilo, C2-4 alquinilo, fluoro-C1-4alquilo, fluoro-C1-4alcoxi-C1-4alquilo o hidroxi-C1-4alquilo, R2 es H, C1-4 alquilo, C3-7 cicloalquilo, C3-7cicloalquil-C1-4alquilo, C1-4alcoxi-C1-4alquilo, C2-4 alquenilo, C2-4 alquinilo, fluoro-C1-4alquilo, o hidroxi-C1-4alquilo; R3 es H, C1-4 alquilo, C3-7 cicloalquilo, C3-7cicloalquil-C1-4alquilo, C1-4alcoxi-C1-4alquilo, fluoro-C1-4alquilo, fluoro-C1-4alcoxi-C1-4alquilo o hidroxi-C1-4 alquilo; R4 es H, C1-4 alquilo, C3-7 cicloalquilo, C3-7cicloalquil-C1-4alquilo, C1-4alcoxi-C1-4alquilo, fluoro-C1-4alquilo, fluoro-C1-4alcoxi-C1-4alquilo, hidroxi-C1-4alquilo, C1-4alcoxi-C1-4alquilcarbonilo, mono- o di-C1-4alquilamino- C1-4alquilcarbonilo o C1-4 alquilcarbonilo o en donde R3 y R4 conjuntamente forman un radical metileno (-CH2-), etileno (-CH2-CH2-), propileno (-CH2-CH2-CH2-) o isopropilideno (-C(CH3)2-); R5 es H, halogeno, C1-4 alquilo o fluoro-C1-4alquilo; R6 es H, halogeno, C1-4 alquilo o fluoro-C1-4alquilo y sus sales.
ARP050101534A 2004-04-26 2005-04-19 Bencimidazoles triciclicos AR048869A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04009793 2004-04-26

Publications (1)

Publication Number Publication Date
AR048869A1 true AR048869A1 (es) 2006-06-07

Family

ID=34924730

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101534A AR048869A1 (es) 2004-04-26 2005-04-19 Bencimidazoles triciclicos

Country Status (8)

Country Link
US (1) US20070244173A1 (es)
EP (1) EP1742951A1 (es)
JP (1) JP2007534680A (es)
AR (1) AR048869A1 (es)
AU (1) AU2005235754A1 (es)
CA (1) CA2563759A1 (es)
TW (1) TW200538456A (es)
WO (1) WO2005103057A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102470126A (zh) 2009-07-09 2012-05-23 拉夸里亚创药株式会社 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8604566D0 (sv) * 1986-10-27 1986-10-27 Haessle Ab Novel compunds
SE9602286D0 (sv) * 1996-06-10 1996-06-10 Astra Ab New compounds
AU736767B2 (en) * 1997-05-28 2001-08-02 Altana Pharma Ag Fused dihydropyrans
CZ20023210A3 (cs) * 2000-03-29 2003-01-15 Altana Pharma Ag Pyrano(2,3-)imidazo(-1,2-a)pyridinová sloučenina
HUP0500330A3 (en) * 2001-08-10 2009-12-28 Altana Pharma Ag Heterocondensated tricyclic imidazopyridines, their use and pharmaceutical compositions containing them
AU2004226180A1 (en) * 2003-04-04 2004-10-14 Altana Pharma Ag Cyclic benzimidazoles

Also Published As

Publication number Publication date
WO2005103057A8 (en) 2006-02-16
CA2563759A1 (en) 2005-11-03
JP2007534680A (ja) 2007-11-29
TW200538456A (en) 2005-12-01
US20070244173A1 (en) 2007-10-18
WO2005103057A1 (en) 2005-11-03
AU2005235754A1 (en) 2005-11-03
EP1742951A1 (en) 2007-01-17

Similar Documents

Publication Publication Date Title
AR055071A1 (es) Derivados de pirrolo (3,2 - b) pirimidina. composiciones farmaceuticas.
UY39526A (es) Inhibidores de kras g12d
ES2485867T3 (es) Compuestos opioides de carboxamido
AR075396A1 (es) Derivados de quinazolinas y composiciones farmaceuticas
AR050953A1 (es) Compuestos de sulfonamida inhibidores de los receptores de cck1/cck2 duales
CO5680403A2 (es) Antagonistas de mchr1r
AR069802A1 (es) Compuestos de carbamoilo como inhibidores de dgat1 190
CO5690593A2 (es) Nuevos derivados de pirimidin 2-amina
ES2604191T3 (es) Inhibidores de tirosina quinasas
CO6220931A2 (es) Inhibidores de serina proteasas para el tratamiento de infecciones de vhc
PE20142081A1 (es) Inhibidores de quinurenina-3-monooxigenasa, composiciones farmaceuticas y metodo de uso de los mismos
CO6190626A2 (es) Compuestos y composiciones como inhibidores de proteasa activadora de canal
EA201000101A1 (ru) Производные пиримидина 934
AR067613A1 (es) Inhibidores de adn-pk, uso y sintesis de los mismos
AR071222A1 (es) Compuestos heterociclicos espirocondensados
AR062797A1 (es) Derivados de piperidina como inhibidores de renina, composiciones farmaceuticas.
CO6321266A2 (es) Inhibidores limk2 compuestos de los cuales estan hechos y metodologia de uso
AR093581A1 (es) Antibioticos macrociclicos de amplio espectro
AR054102A1 (es) Derivados de fenil-piperazina-metanona. procesos de obtencion y composiciones farmaceuticas
AR081828A1 (es) Compuestos de biguanida y su uso para el tratamiento del cancer
AR066604A1 (es) Derivados de arilamida pirimidona, medicamentos que los contienen y usos terapeuticos para prevenir y/o tratar enfermedades neurodegenerativas fundamentalmente.
CO5601021A2 (es) Derivados de quinazolinona, composiciones farmaceuticas que los contienen y su proceso de preparacion y su uso como antagonistas cb
UY30787A1 (es) "inhibidores benzoimidazolicos de trpv1"
RS54120B1 (en) Pyridinyl-I pyrazinyl-methyloxyaryl derivatives USED AS INHIBITORS OF TYROSINE KINASE TREATMENT (SYK)
AR054132A1 (es) Derivados de azolopiridin-2-ona como inhibidores de lipasas y fosfolipasas

Legal Events

Date Code Title Description
FB Suspension of granting procedure